Heung-Joon Yang
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Heung-Joon Yang
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada.
4
| Extinct | Pharmaceuticals: Major | 4 |
| Public Company | Industrial Conglomerates | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Heung-Joon Yang via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Director/Board Member | |
Collected Mind Ltd.
 Collected Mind Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Collected Mind Ltd. functions as an investment holding There is no available country named vg company. | Financial Conglomerates | Chairman | |
Zhejiang Sunshine Pharmaceutical Co., Ltd.
 Zhejiang Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Zhejiang Sunshine Pharmaceutical Co., Ltd. is a company that manufactures pharmaceutical products. The company is based in Zhejiang, China. | Pharmaceuticals: Major | Director/Board Member | |
| Shenzhen Baishitong Technology Development Co., Ltd. | Director/Board Member | ||
| Taizhou Huan Sheng Investment Management Co., Ltd. | College/University | Chairman | |
Excel Partner Holdings Ltd.
 Excel Partner Holdings Ltd. MiscellaneousMiscellaneous Part of 3SBio, Inc., Excel Partner Holdings Ltd. operates as a holding Chinese company. The company is based in Hong Kong, Hong Kong. Excel Partner Holdings was acquired by 3SBio, Inc. from First Shanghai Investments Ltd. on December 31, 2014 for $25.25 million. | Miscellaneous | Director/Board Member | |
Hong Kong Sansheng Ltd.
 Hong Kong Sansheng Ltd. Financial ConglomeratesFinance Part of Hong Kong Sansheng Group Ltd., Hong Kong Sansheng Ltd. operates as an investment holding company. The company is based in Hong Kong, Hong Kong. | Financial Conglomerates | Director/Board Member | |
| Liaoning Sunshine Science & Technology Development Co. Ltd. | Chief Executive Officer | ||
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | Chief Executive Officer | ||
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
 Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and operation of new bioengineered drugs, genetically engineered vaccines, new pharmaceutical preparations, purified water, and distilled water. The company was founded on March 22, 1999 and is headquartered in Shenzhen, China. | Pharmaceuticals: Major | Chairman | |
| China Europe International Business School | College/University | Masters Business Admin | |
| Shanghai Second Medical University | College/University | Undergraduate Degree | |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Doctorate Degree | |
| 3SBIO INC. | Biotechnology | Chief Executive Officer | |
| SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Director/Board Member | |
| Shanghai Aoxi Technology Information Consulting Co., Ltd. | Director/Board Member | ||
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
 Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Pharmaceuticals: Major | Chairman | |
Walking Fish Therapeutics, Inc.
 Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Secretary | |
| AETERNA ZENTARIS INC. | Pharmaceuticals: Major | President | |
| University of Regensburg | College/University | Undergraduate Degree | |
| Technische Universität Braunschweig | College/University | Doctorate Degree | |
| Zentaris GmbH | President | ||
| The Wyatt Group LLC | Miscellaneous | Founder | |
| Hampshire College | College/University | Graduate Degree | |
| Shanghai National Engineering Research Center of Antibody Medi | Director/Board Member | ||
Ample Harvest Investments Ltd.
 Ample Harvest Investments Ltd. Financial ConglomeratesFinance Part of 3SBio, Inc., Ample Harvest Investments Ltd. provides investment services. | Financial Conglomerates | Director/Board Member | |
| Full Gain Pharmaceutical Ltd. | Director/Board Member | ||
Guangdong Sunshine Pharmaceutical Co., Ltd.
 Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Pharmaceuticals: Major | Chairman | |
Hongkong Sansheng Medical Ltd.
 Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Pharmaceuticals: Major | Director/Board Member | |
Strategic International Group Ltd.
 Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Pharmaceuticals: Major | Chairman | |
Shanghai Xingsheng Pharmaceutical Co., Ltd.
 Shanghai Xingsheng Pharmaceutical Co., Ltd. Financial ConglomeratesFinance Shanghai Xingsheng Pharmaceutical Co., Ltd. engages in the investment and transfer of technologies. Its business includes research and development of biological products, genetic engineering products, Chinese and western medicines, and biochemical reagents. The company was founded on December 23, 1998 and is headquartered in Shanghai, China. | Financial Conglomerates | Chairman | |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Biotechnology | Chairman | |
| Harvard Business School | College/University | Masters Business Admin | |
Isotechnika, Inc.
 Isotechnika, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika, Inc. operates as an international biopharmaceutical company. The firm discovers and develops immunosuppressive therapeutic drugs for treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. The company is headquartered in Edmonton, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
| BELLUS HEALTH | Pharmaceuticals: Major | Director/Board Member | |
| NEMO Fund, Inc. | Founder | ||
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Medical/Nursing Services | Director/Board Member | |
| EMISPHERE TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 19 |
| China | 16 |
| Canada | 6 |
| Hongkong | 5 |
| Duitsland | 4 |
Sectoraal
| Health Technology | 20 |
| Consumer Services | 10 |
| Finance | 9 |
| Miscellaneous | 4 |
| Commercial Services | 2 |
Operationeel
| Director/Board Member | 49 |
| Independent Dir/Board Member | 16 |
| Chairman | 10 |
| Corporate Officer/Principal | 7 |
| Chief Executive Officer | 6 |
Sterkste connecties
| Insiders | |
|---|---|
| Franklin Berger | 41 |
| Jing Lou | 25 |
| Jürgen Engel | 6 |
| Donald W. Wyatt | 5 |
| Jeong-Gyu Park | 1 |
- Beurs
- Insiders
- Heung-Joon Yang
- Bedrijfsconnecties
